Behind The Labs

The five studies explored how everyday substances, medications, and biological targets can have unexpected effects on human health. They looked at caffeine and cellular aging, sugary drinks and gastric cancer, semaglutide and respiratory disease, GPR133 and osteoporosis, and a DNA-based treatment for high cholesterol. Although the topics are different, each study identified a biological mechanism that could potentially be used to improve health or better understand disease.Together, the studies also show the importance of distinguishing promising research from proven medical treatments. Several findings came from animal models or observational data, meaning they provide important clues but do not establish cause and effect or guarantee that the same results will occur in humans. Overall, the research highlights how understanding cellular pathways can reveal unexpected connections between common exposures, medications, and disease.Overall, we found the following:☕ Caffeine: May activate AMPK, a cellular pathway involved in energy balance, stress responses, and aging.🥤 Sugary drinks: Daily consumption was associated with a substantially higher risk of gastric cancer, although causation remains unproven.💉 Semaglutide: Was associated with nearly 40% fewer asthma attacks, suggesting possible benefits beyond diabetes and weight loss.🦴 GPR133: Activating this receptor with AP503 strengthened bones in mice and could represent a future osteoporosis treatment target.🧬 PCSK9 DNA therapy: A single injection reduced cholesterol by 47% in mice, showing potential for a new gene-targeting approach to cholesterol treatment.

Today on Behind The Labs, we're diving into four stories reshaping how we think about the body and brain. First, we're debunking a 50-year-old myth: Linus Pauling's vitamin C megadose theory doesn't hold up against modern meta-analyses, which show at best a modest reduction in severe cold symptoms — not prevention. Then, we head into the operating room, where a new "double-punch" nanoparticle platform is helping surgeons see and destroy glioblastoma cells beyond what the eye or scalpel can reach, producing 100% survival in treated mice. From there, we trace how childhood trauma physically reshapes the brain — researchers have identified an enzyme, SETD7, that leaves a molecular "scar" on DNA packaging, priming stress genes to fire more easily decades later, and remarkably, they were able to block it. We'll also unpack a compound called TOFA that helps the body burn fat and preserve muscle simultaneously, offering a promising complement to GLP-1 drugs like Ozempic. And finally, we ask: could learning a new language be the secret to a younger brain? New research suggests multilingual speakers may have brains up to 13 years younger than their monolingual peers. Four studies, one throughline: the brain and body are far more malleable — and far more responsive to what we do to them — than we often assume.

In this episode of Behind The Labs, we opened with adolescence: UC San Diego followed more than 11,000 kids in the ABCD Study from ages 9 and 10 through 16 and 17, verifying cannabis exposure with hair, urine, and saliva rather than trusting self-report, and found that teens who started using didn't decline — they stopped improving, with memory, attention, language, and processing speed flattening out while their peers kept climbing, with THC looking like the driver. From there we went to the University of Zurich, where researchers overturned a textbook rule by watching living mouse brains for weeks and discovering a population of regenerative astrocytes that repair damaged tissue in a genuinely bizarre way — dividing and then sending newly formed daughter-cell nuclei gliding long distances through their own extensions to reknit the network from the inside. Next we got into why deep brain stimulation actually works for Parkinson's: a team from Cologne, Düsseldorf, Harvard, and Charité recorded from implanted electrodes and MEG simultaneously across 50 patients and 100 hemispheres, and found the subthalamic-to-frontal-cortex network communicates in the high beta band, 20 to 35 Hz, with connection strength tracking how much patients' motor symptoms improved — a possible route to tuning DBS by network instead of trial and error. And we closed in the brain's plumbing, where a University of Rochester team used a physics-informed AI to pull fluid velocities out of MRI for the first time and found the glymphatic system clears waste along two routes at wildly different speeds — a few microns per second near the surface, roughly 50 times slower deep in the tissue — with the long-term goal of screening people for sluggish circulation before Alzheimer's ever appears.

In this episode we looked at how cancer's own super-enhancer-driven growth program physically snaps its DNA, creating repeated break-and-repair cycles that may generate the mutations fueling tumor evolution. We then covered EPS8, an aging protein that hyperactivates RAC signaling and drives the toxic protein aggregation behind Huntington's and ALS — knocking it down cleared aggregates in both worms and human cells. Third, an antisense oligonucleotide targeting the glycine transporter SLC6A20 restored NMDA receptor function and social behavior in adult autism model mice, with the same effect reproduced in human cortical organoids. We also broke down a 150,000-person, 30-year cohort showing that just 90 to 120 minutes of strength training a week tracks with 13% lower all-cause mortality, and up to 45% when paired with regular aerobic exercise. Finally, we ended on evolution: Indigenous Andeans carry more copies of the starch-digesting AMY1 gene than any known population, a signature selected for after potato farming began roughly 10,000 years ago.

In this episode of Behind the Labs, we explore four exciting studies that showcase how advances in artificial intelligence, neuroscience, metabolism, and gene editing are shaping the future of medicine. We discuss new research revealing that popular AI-powered calorie tracking apps significantly underestimate calorie and fat intake, highlighting the importance of using these tools cautiously. We also examine how a single dose of psilocybin may temporarily reshape brain activity, increase psychological insight, and improve well-being, offering new clues about its potential role in treating depression and other mental health disorders.The episode also covers a promising obesity treatment discovered using artificial intelligence—a naturally occurring peptide called BRP that produced Ozempic-like weight loss in animal studies while avoiding many common side effects. We then dive into groundbreaking neuroscience research showing that autism-like symptoms caused by prenatal inflammation in mice could be rapidly improved by targeting brain signaling pathways, suggesting that the adult brain may be more adaptable than previously believed. F

This episode dives into four major discoveries reshaping how scientists understand brain and muscle aging. We start with a Duke-NUS study showing exercise fights age-related muscle loss by correcting a molecular imbalance driven by the gene DEAF1, which disrupts the cell's ability to clear damaged proteins as we age. From there we shift to the brain, exploring a King's College London discovery of "karyoptosis," a newly identified cell death process that may explain how toxic protein buildup kills neurons in Alzheimer's and frontotemporal dementia, pointing to a specific molecular target (p38 MAP kinase and LaminB1) for future therapies.We then turn to sleep, unpacking UC Berkeley research that maps the brain circuitry linking deep sleep to growth hormone release, revealing a feedback loop between hormone levels and the brain's alertness center that helps explain why poor sleep disrupts growth, metabolism, and recovery. Finally, we explore the mystery of cognitive resilience, discussing a Netherlands Institute for Neuroscience study on why some people stay mentally sharp despite Alzheimer's pathology in their brains, with early evidence pointing to rare "immature neurons" that behave differently in resilient individuals, not by growing in number, but by activating survival programs that may help protect surrounding brain tissue. Together, these studies highlight a common thread: aging and disease resistance often come down to how cells manage stress, repair, and communication rather than simple decline.

In this episode of Behind The Labs, we broke down five major research studies pushing the boundaries of neuroscience and medicine. We covered Northwestern's experimental drug NU-9, which may prevent Alzheimer's before symptoms ever appear by targeting a newly identified toxic amyloid subtype. We then talked about Japanese researchers engineering a supercharged vitamin K compound that can actually regenerate lost neurons — a first for the field. Johns Hopkins blew our minds with pea-sized lab-grown brains that can distinguish schizophrenia from bipolar disorder with 92% accuracy, opening the door to personalized psychiatric treatment. On the prevention side, a massive meta-analysis confirmed that eating legumes and soy foods daily can cut hypertension risk by nearly 30%, and NYU researchers found a simple blood test that detects depression through accelerated immune cell aging — before you even feel it. The big theme across all of it: medicine is shifting from treating disease after the damage is done to catching and stopping it years earlier.

Today at Behind The Labs, we’re looking at five recent health-related studies that sound very different on the surface: exercise, dementia, Alzheimer’s disease, semaglutide, and creatine.But there’s a common theme across all of them: health is not just about one organ, one habit, or one simple cause. The brain affects endurance. Speech may reveal cognitive decline. Blood vessels may shape Alzheimer’s disease. Weight-loss medication may help older adults but still requires caution. Creatine may support more than muscle.

In this episode of Behind the Labs, we explore cutting-edge research that’s reshaping how we understand sleep, brain health, and chronic pain. We start with a clinical trial on solriamfetol, a wake-promoting drug showing promising results for early morning shift workers—a group often overlooked despite facing major circadian rhythm disruptions. The findings highlight how aligning (or misaligning) with our biological clock can dramatically impact alertness, performance, and overall well-being. We also dive into a Lancet-published study on sulthiame, a potential game-changer for obstructive sleep apnea, offering hope for patients who struggle with traditional CPAP therapy by directly improving breathing regulation during sleep.Beyond sleep, we unpack research on lifelong cognitive engagement and its link to reduced Alzheimer’s risk, emphasizing the idea of “cognitive reserve” and how habits like reading and learning may delay neurodegeneration by years. Finally, we discuss groundbreaking neuroscience uncovering a brain circuit in the insular cortex that may actively sustain chronic pain—challenging the notion that pain simply lingers after injury. Together, these studies reveal how deeply interconnected our brain, behavior, and biology are, while pointing toward innovative treatments that could transform patient care in the future.

In this episode of Behind the Labs, we explored a series of studies that challenge some of the most fundamental assumptions in biology and medicine. From the brain to the lungs to individual cells, researchers are uncovering active, dynamic systems where we once thought processes were passive. We discussed how astrocytes—long considered mere support cells—actually play a direct role in encoding and controlling fear memories, reshaping how we understand emotional regulation and disorders like PTSD. We also looked at a breakthrough in gene therapy that successfully restored hearing in patients with genetic deafness, highlighting the growing potential of precision medicine to not just manage, but potentially cure sensory disorders.We then turned to aging and disease, examining how changes in lung tissue—not just immune decline—can drive severe outcomes in infections like COVID-19 through runaway inflammation. Finally, we covered a discovery showing that cells actively transport proteins using internal “trade winds,” challenging the classic diffusion model and offering new insight into processes like wound healing and cancer metastasis. Together, these studies paint a picture of biology as far more active, interconnected, and targetable than previously thought—opening the door to entirely new therapeutic strategies.

In this episode of Behind the Labs, we explore several new studies that reveal how everyday exposures and biological processes can influence human health. We begin with the VIVID clinical trial, which tested whether high-dose vitamin D supplements could reduce the severity of COVID-19 or prevent infection within households. While the study found no meaningful effect on acute illness or transmission, researchers observed a possible small reduction in long-COVID symptoms among participants who closely followed the supplementation regimen. We also discuss research on paternal nicotine exposure, where scientists discovered that nicotine use in fathers before conception altered metabolic pathways in their offspring, suggesting that a father’s health habits may influence the long-term disease risk of future children.The episode then shifts to environmental and neurological health, highlighting a systematic review suggesting that microplastics could contribute to neurodegenerative diseases such as Alzheimer’s and Parkinson’s through mechanisms like inflammation, oxidative stress, and mitochondrial dysfunction. We also cover a study showing that THC intoxication can significantly impair multiple types of memory, including prospective memory and source memory, even at moderate doses. Finally, we examine new research linking cellular energy metabolism to depression, where abnormal ATP production patterns may help explain fatigue and cognitive symptoms in patients, as well as a clinical trial showing that the drug sulthiame may reduce breathing interruptions in obstructive sleep apnea, offering a potential alternative treatment to CPAP machines. Together, these studies highlight how advances in biomedical research continue to uncover unexpected connections between environment, behavior, and disease.

This week on Behind the Labs, we break down four cutting-edge studies reshaping how we think about metabolism, aging, cancer therapy, and early development. First, researchers show that reducing specific amino acids in the diet can boost thermogenesis and fat burning in mice—without more exercise. Next, a UCLA team reveals why aging muscle stem cells slow down: a survival protein keeps them alive longer but at the cost of repair speed.We also explore an innovative cancer strategy using engineered bacteria to infiltrate and consume oxygen-starved tumor cores, and a promising stem cell trial aiming to restore dopamine-producing neurons in Parkinson’s disease. Finally, new genome-mapping technology overturns the “blank slate” model of early embryos, showing DNA is highly organized far earlier than scientists thought. Together, these studies highlight a common theme in modern biology: powerful trade-offs underlie many of the body’s most important systems.

This week on Behind the Labs, we’re diving into five studies that challenge what we think we know about the brain, the body, and even what makes us human.Let’s start with something almost philosophical. Researchers showed that a bonobo named Kanzi can track imaginary objects in controlled experiments — like pretend juice being poured into a cup. He consistently identified where the “imaginary” object was, even after the cups were moved. That’s a big deal because imagination — the ability to mentally represent something that isn’t physically there — has long been considered uniquely human. If apes share even part of that ability, it suggests imagination may have evolutionary roots going back millions of years.Next, shifting to human health — a large U.S. study found that people with the highest intake of ultra-processed foods had a 47% higher risk of cardiovascular disease. These foods now make up about 60% of adult diets in the U.S. The concern isn’t just calories — it’s how heavily altered these foods are and how they may drive inflammation and metabolic dysfunction. It raises the question: are we engineering convenience at the cost of long-term cardiovascular health?On a more specific nutrition note, another study found that older adults who don’t consume enough lycopene — the antioxidant found in tomatoes — have significantly higher odds of severe gum disease. What’s interesting is that the protective effect varied by race and sex, pointing to deeper health disparities that diet alone may not fully explain.In mental health research, the most comprehensive review ever conducted on ADHD treatments confirmed that medication remains the most evidence-supported intervention for both children and adults, with cognitive behavioral therapy strongly supported for adults. Many alternative approaches showed weaker evidence. The researchers even launched an interactive platform to help patients and clinicians navigate treatment options more transparently — which speaks to how overwhelming and contradictory mental health advice can feel.Then there’s AI in medicine. A new system called Prima can analyze brain MRIs in seconds with up to 97.5% accuracy, automatically flagging urgent conditions like stroke. It integrates imaging with patient history — almost like a radiologist co-pilot. In a health system strained by backlogs and specialist shortages, that kind of speed could genuinely change outcomes.And finally — jet lag might someday be solved at the genetic level. Scientists discovered a compound called Mic-628 that directly activates a core circadian gene, effectively pushing the body’s internal clock forward. In animal models, it cut jet lag recovery nearly in half. Unlike melatonin, it doesn’t depend on precise timing. It works through the molecular mechanics of the clock itself.Across all these studies, there’s a common thread: we’re moving from observing biology to directly understanding and influencing its underlying mechanisms — whether that’s imagination in apes, inflammation from food, neural attention systems, real-time medical imaging, or the genes that keep time inside our cells.And that’s what we love about science — it keeps pushing the boundary of what we thought was uniquely human, uniquely biological, or simply impossible.

In this episode, we dive into a series of powerful new studies showing how early detection, lifestyle choices, and cutting-edge therapies are reshaping the future of medicine. We begin with groundbreaking research from Sinai Health revealing a blood test that may predict the risk of Crohn’s disease years before symptoms appear—opening the door to prevention rather than damage control. From there, we explore work from the AdventHealth Research Institute showing that consistent aerobic exercise can make the brain appear biologically younger, highlighting how everyday habits in midlife may protect long-term cognitive health.We then turn to transformative findings from Stanford Medicine, where scientists successfully regenerated joint cartilage in aging and injured mice by blocking an aging-related enzyme—raising real hope for disease-modifying treatments for osteoarthritis that could reduce the need for joint replacement. The episode also covers long-term results from the RECOVER trial led by Washington University School of Medicine, where vagus nerve stimulation produced sustained, life-changing improvements for people with the most severe forms of treatment-resistant depression. Finally, we unpack emerging (and controversial) evidence suggesting that ibuprofen’s anti-inflammatory effects may influence cancer risk—while emphasizing why self-medication is not the answer.Together, these studies paint a compelling picture: medicine is moving earlier, deeper, and more personalized—shifting from managing symptoms to predicting risk, restoring function, and improving quality of life over the long term.

In this episode of Behind the Labs, we zoom out and connect the dots across some of the most compelling recent research shaping how we think about health, disease, and prevention. We explore how scientists are uncovering the earliest biological triggers of Alzheimer’s disease, from toxic amyloid subtypes and reactive astrocytes to experimental drugs that may stop damage before memory loss begins. We also dive into breakthrough work on mitochondria and healthy aging, where boosting cellular energy production extended both lifespan and healthspan in animal models—improving metabolism, endurance, and reducing markers of cellular aging.We then turn to the often-overlooked parts of our genome, discussing how researchers are mapping hidden DNA switches in astrocytes that regulate brain genes linked to Alzheimer’s and other neurological disorders, and how AI models are now being trained on this data. Finally, we tackle real-world prevention, breaking down large-scale evidence on alcohol use and cancer risk, and emerging research on cannabis-derived compounds as potential cancer therapies. From molecular mechanisms to public health implications, this episode ties together how early intervention, gene regulation, metabolism, and lifestyle intersect—offering a big-picture view of where modern biomedical research is heading, and what it could mean for the future of medicine. 🧠🧬🔬

In this episode of Behind the Labs, we explore four groundbreaking discoveries that reveal just how deeply our bodies and brains are connected. From how muscle mass keeps your brain young, to the hidden ways cancer shape-shifts, to immune cells that repair muscle using neuron-like signals, and finally a surprising pathway linking hypertension to early brain aging — this episode breaks down the science you need to know.We’ll discuss:• How building muscle and reducing visceral fat may literally reverse your brain’s biological age• New insights into why certain cancers “change identity” and how that could unlock safer, ultra-targeted treatments• A surprising discovery that immune cells can act like neurons to kick-start rapid muscle repair• Why high blood pressure might damage the brain before your numbers even rise — and how an existing drug could help protect memoryJoin us as we connect the dots on the newest research shaping the future of aging, healing, and disease treatment. Whether you’re into neuroscience, fitness, medicine, or just love good science stories, this episode has something for you.

Welcome back to Behind The Labs. In this episode, we dive into groundbreaking new research reshaping how we understand mental health, aging, and the brain. From genetic testing that could predict the best antidepressant for each person, to discoveries showing how rebalancing specific brain circuits can reverse anxiety, to the surprising link between long-term melatonin use and heart failure risk, and even new gene-editing breakthroughs that restore memory in aging brains—scientists are redefining what’s possible. Join us as we unpack these studies, explore their implications for personalized medicine and mental health care, and discuss how close we really are to a future where treatment is tailored to your DNA and neural circuitry.

Join us Behind The Labs as we dive deep into some more interesting studies this week with interesting topics!

Join us Behind The Labs as we dive into some more exciting studies that cover a wide range of topics today!

Join us Behind The Labs as we dive into the newest and most innovative studies of the week!

In this episode, we discuss the latest advancements in medical research, starting with a revolutionary gene therapy that could halt Alzheimer’s progression by reprogramming brain cells. We explore MIT’s groundbreaking AI implant that enhances HIV vaccine effectiveness with a single dose. We also cover a new implantable device that restores movement in paralyzed rats, offering hope for spinal cord injury treatments. We dive into USC’s new wireless ultrasound device that provides drug-free relief for chronic pain. Lastly, we look at how a tiny implantable electronic device helps restore function to rats with spinal cord injuries, potentially leading to human treatments.

Join us Behind The Labs as we come back from a quick hiatus to bring more excitement with new studies. n this episode, we explore the latest advancements in health and science, starting with a groundbreaking study on a non-opioid painkiller, SBI-810, that offers long-lasting pain relief without addiction. We also delve into the potential of psilocybin for treating depression in cancer patients, discuss the development of a painless, non-invasive nanoneedle patch for cancer detection, and highlight the overlooked health benefits of creatine beyond athletics, including its role in aging and cognitive function.

Special episode alert! We've collaborated with YegMDPod to join forces, as we talked with their host Jessica B. about Med School life, the Medicine Program and its' benefits here at the University of Alberta, and how research plays a part in Medicine, among countless other sub conversations! You won't want to miss this one!

Join us yet again at Behind The Labs as we've got a new and rich batch of innovative and head-scratching research studies and breakthroughs for you to wrap your head around!

Join us Behind The Labs as we dive right into some insightful studies on Alzheimer's rate reduction via physical activity, new AI technology on wearable ECG tech, and how science has looked at the mechanics of consciousness in a new light.

Join us on another episode of Behind The Labs as we dive into more trail-blazing scientific research studies!

Join us on another episode of Behind The Labs as we dive into some different and unique studies with research breakthroughs that continue to break barriers and boundaries.

Join us Behind The Labs as we dive into some studies that provide introspection on much needed scientific questions and research.

Join us Behind The Labs as we seek a deeper understanding of some more breakthrough research studies and news!

Join us Behind The Labs as again, we dive into some revolutionary and barrier-breaking studies that have real-world impact!

Join us on another episode of Behind The Labs as we venture into a variety of new and exciting studies to cover for our listeners!

Join us Behind The Labs as we dive into some more exciting and interesting studies today!

Join us Behind The Labs as we dive into intriguing studies from various studies on this episode!

Join us Behind The Labs in Episode 30 where we dive into fascinating new topics!

Join Us Behind The Labs as we dive into topics like inhalable medication for lung cancer, non-opioid painkillers for post-op pain, and how far robotics in the medical field has advanced!

Join us Behind The Labs as we have an insightful conversation with Dr. Ben Dyson, behind the RE:COGNITION Lab at the University of Alberta

Join us Behind The Labs as we dive into today's exciting studies!

Join us Behind The Labs as we have an interesting conversation with Pharmacology PhD and PMCOL 200 professor Anna Taylor about pharmacology now, where it stands, and the future of this discipline.

Join us Behind The Labs as we chat with Dr. Myron Zwozdesky and have an insightful conversation about his perspectives on pharmacology and drug abuse in society today!

Join us Behind The Labs to learn about more new science breakthroughs, research, and studies!

Join us Behind The Labs to learn more about future science breakthroughs and research!

Join us Behind The Labs as we dive deep into some studies about a promising cure for HIV with a different approach, dormant stem cells that could help regenerative brain therapies, and a new EV battery that promises better efficiency!

Join us Behind The Labs as we go over topics like the new discovery of water under Mars’ crust, what experts evaluate as AI’s threat to humanity, along with a treatment that helps regenerate cartilage made from your own body!

Join us at Behind The Labs as we have an incredibly insightful conversation with Dr. Daniel Graf, a professor and researcher currently at UBC, where we speak across different topics ranging from new technology in research, advice for prospective researchers, and his personal life lessons and thoughts on the current ever-evolving world of research.

Join us Behind The Labs as we go over recent studies including discussions of Olympic athlete's peak ages, a promising cancer-related HIV drug, and how the placebo effect works and its' potential usefulness.

Join us Behind The Labs as we go over recent studies involving CTE and Parkinson’s disease similarities, what modifications risk factors have to do with cancer prevalence, and a breakthrough in osteoarthritis treatment with cartilage recovery molecules.

Join us today Behind The Labs as we speak about the science behind sleep and the waves and sleep stages, how AI is working currently in science and how it's become an integral part of professional and personal life all of a sudden, and how antibiotics given to children can induce changes in the gut microbiota and have a detrimental effect in asthma predisposed patients.

Join us Behind The Labs today as we yet again dive deep into the world of recent scientific breakthroughs; namely the new development of 3D Drug Printing, the use of RNA Splicing to target exons, and a new promising device to give lab access to the entire world using a Lab-On-A-Chip device?

Join us at Behind The Labs as today we speak to the highly esteemed Dr. Shereen Hamza once again on some new, insightful studies and gain an expert's approach and perspective on some novel biological research.

Join us Behind The Labs as today we go over studies that explore the research into immunotherapy, the biological and psychological factors underlying paranoia, and how AI has been seemingly used in the ER to help physicians prioritize and be more efficient!